454 related articles for article (PubMed ID: 30977109)
21. Exploring a Safety Signal of Antipsychotic-Associated Pneumonia: A Pharmacovigilance-Pharmacodynamic Study.
Cepaityte D; Siafis S; Egberts T; Leucht S; Kouvelas D; Papazisis G
Schizophr Bull; 2021 Apr; 47(3):672-681. PubMed ID: 33289848
[TBL] [Abstract][Full Text] [Related]
22. Antidepressant use and risk of adverse outcomes in older people: population based cohort study.
Coupland C; Dhiman P; Morriss R; Arthur A; Barton G; Hippisley-Cox J
BMJ; 2011 Aug; 343():d4551. PubMed ID: 21810886
[TBL] [Abstract][Full Text] [Related]
23. Postmarketing safety profile of brexanolone: a pharmacovigilance analysis based on FDA Adverse Event Reporting System (FAERS).
Zhang M; Xie W; Li J; Zheng J; Zhou Y
Arch Womens Ment Health; 2024 Feb; 27(1):35-44. PubMed ID: 37831172
[TBL] [Abstract][Full Text] [Related]
24. The importance of drug-drug interactions as a cause of adverse drug reactions: a pharmacovigilance study of serotoninergic reuptake inhibitors in France.
Montastruc F; Sommet A; Bondon-Guitton E; Durrieu G; Bui E; Bagheri H; Lapeyre-Mestre M; Schmitt L; Montastruc JL
Eur J Clin Pharmacol; 2012 May; 68(5):767-75. PubMed ID: 22116460
[TBL] [Abstract][Full Text] [Related]
25. Exploring the association between selective serotonin reuptake inhibitors and rhabdomyolysis risk based on the FDA pharmacovigilance database.
Wang Y; Lin Y; Lin Q; Liang H; Cai W; Jiang D
Sci Rep; 2023 Jul; 13(1):12257. PubMed ID: 37507539
[TBL] [Abstract][Full Text] [Related]
26. Drugs and bruxism: A study in the World Health Organization's pharmacovigilance database.
Montastruc JL
Br J Clin Pharmacol; 2023 Dec; 89(12):3765-3768. PubMed ID: 37574820
[TBL] [Abstract][Full Text] [Related]
27. Serotonin syndrome by drug interactions with linezolid: clues from pharmacovigilance-pharmacokinetic/pharmacodynamic analysis.
Gatti M; Raschi E; De Ponti F
Eur J Clin Pharmacol; 2021 Feb; 77(2):233-239. PubMed ID: 32901348
[TBL] [Abstract][Full Text] [Related]
28. [Antidepressive agents and hyponatremia: A literature review and a case/non-case study in the French Pharmacovigilance database].
Rochoy M; Zakhem-Stachera C; Béné J; Berkhout C; Gautier S;
Therapie; 2018 Oct; 73(5):389-398. PubMed ID: 29773358
[TBL] [Abstract][Full Text] [Related]
29. The Impact of Serotonin Transporter Binding Affinity on the Risk of Bleeding Related to Antidepressants.
Gahr M; Connemann BJ; Muche R; Zeiss R
J Clin Psychopharmacol; 2021 Jul-Aug 01; 41(4):470-473. PubMed ID: 34181363
[TBL] [Abstract][Full Text] [Related]
30. Data-mining for detecting signals of adverse drug reactions of fluoxetine using the Korea Adverse Event Reporting System (KAERS) database.
Kim S; Park K; Kim MS; Yang BR; Choi HJ; Park BJ
Psychiatry Res; 2017 Oct; 256():237-242. PubMed ID: 28646789
[TBL] [Abstract][Full Text] [Related]
31. Role of serotonin and norepinephrine transporters in antidepressant-induced arterial hypertension: a pharmacoepidemiological-pharmacodynamic study.
Montastruc JL; Rousseau V; de Canecaude C; Roussin A; Montastruc F
Eur J Clin Pharmacol; 2020 Sep; 76(9):1321-1327. PubMed ID: 32483650
[TBL] [Abstract][Full Text] [Related]
32. Ubrogepant and rimegepant: signal detection using spontaneous reports of adverse events from the Food and Drug Administration Adverse Event Reporting System.
Battini V; Carnovale C; Clementi E; Sessa M
Expert Opin Drug Saf; 2023; 22(11):1105-1112. PubMed ID: 37293948
[TBL] [Abstract][Full Text] [Related]
33. What can we learn from consumer reports on psychiatric adverse drug reactions with antidepressant medication? Experiences from reports to a consumer association.
Vilhelmsson A; Svensson T; Meeuwisse A; Carlsten A
BMC Clin Pharmacol; 2011 Oct; 11():16. PubMed ID: 22026961
[TBL] [Abstract][Full Text] [Related]
34. Analysis of the Frequency and Onset Time of Hyponatremia/Syndrome of Inappropriate Antidiuretic Hormone Induced by Antidepressants or Antipsychotics.
Takeda K; Kobayashi C; Nakai T; Oishi T; Okada A
Ann Pharmacother; 2022 Mar; 56(3):303-308. PubMed ID: 34210184
[TBL] [Abstract][Full Text] [Related]
35. A real-world disproportionality analysis of FDA Adverse Event Reporting System (FAERS) events for baricitinib.
Peng L; Xiao K; Ottaviani S; Stebbing J; Wang YJ
Expert Opin Drug Saf; 2020 Nov; 19(11):1505-1511. PubMed ID: 32693646
[TBL] [Abstract][Full Text] [Related]
36. [Hyponatremia associated with SSRI/NRSI: Descriptive and comparative epidemiological study of the incidence rates of the notified cases from the data of the French National Pharmacovigilance Database and the French National Health Insurance].
Revol R; Rault C; Polard E; Bellet F; Guy C
Encephale; 2018 Jun; 44(3):291-296. PubMed ID: 29248119
[TBL] [Abstract][Full Text] [Related]
37. Safety Profile of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors: A Disproportionality Analysis of FDA Adverse Event Reporting System.
Huang J; Meng L; Yang B; Sun S; Luo Z; Chen H
Sci Rep; 2020 Mar; 10(1):4803. PubMed ID: 32179761
[TBL] [Abstract][Full Text] [Related]
38. Withdrawal Syndrome Following Discontinuation of 28 Antidepressants: Pharmacovigilance Analysis of 31,688 Reports from the WHO Spontaneous Reporting Database.
Gastaldon C; Schoretsanitis G; Arzenton E; Raschi E; Papola D; Ostuzzi G; Moretti U; Seifritz E; Kane JM; Trifirò G; Barbui C
Drug Saf; 2022 Dec; 45(12):1539-1549. PubMed ID: 36400895
[TBL] [Abstract][Full Text] [Related]
39. Syndrome of inappropriate antidiuretic hormone secretion is associated with different proton pump inhibitor use: a pharmacovigilance study.
Wang M; Zhang L; Jia M; Wang J; Shen Z; Wang S; Zhang X; Xu J; Zheng Z; Lv X; Zong X; Li H; Zhou J; Meng T; Chen M; Zhao B; Gong J
BMC Nephrol; 2022 May; 23(1):191. PubMed ID: 35590283
[TBL] [Abstract][Full Text] [Related]
40. Novel Adverse Events of Iloperidone: A Disproportionality Analysis in US Food and Drug Administration Adverse Event Reporting System (FAERS) Database.
Subeesh V; Maheswari E; Singh H; Beulah TE; Swaroop AM
Curr Drug Saf; 2019; 14(1):21-26. PubMed ID: 30362421
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
